# ENDRA Life Sciences Inc.: Form 8-K, filed Dec 15, 2025

- Company: [ENDRA Life Sciences Inc.](/companies/ndra.md) (CIK 1681682)
- Form: 8-K
- Filed: 2025-12-15
- Accepted by EDGAR: Dec 12, 2025, 20:31 ET
- Period: 2025-12-09
- Accession: 0001213900-25-121374
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1681682/000121390025121374/ea0269386-8k_endra.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1681682/000121390025121374/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1681682/000121390025121374/ea0269386-8k_endra.htm

Filed Dec 15, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-121374. Last ingested by Listed: Nov 10, 2026, 17:03 ET. No prices; not investment advice.